东方生物 （688298.SH）
25.42 -3.73（-12.800%）
+ 收藏
今开：26.80 最高：27.99 成交量：6.33万手
昨收：29.15 最低：25.41 成交额：1.67亿
利润表（东方生物）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 657,613,863.02 | 418,235,233.09 | 182,922,481.69 | 820,157,331.67 | 652,171,856.12 | 501,543,883.09 | 376,045,281.02 |
| 营业收入(元) | 657,613,863.02 | 418,235,233.09 | 182,922,481.69 | 820,157,331.67 | 652,171,856.12 | 501,543,883.09 | 376,045,281.02 |
| 二、营业总成本(元) | 1,015,757,409.45 | 624,188,833.28 | 286,548,849.54 | 1,002,299,363.55 | 718,719,790.87 | 457,566,614.10 | 424,274,588.63 |
| 营业成本(元) | 429,479,876.84 | 269,301,346.85 | 123,745,857.61 | 467,402,664.29 | 409,985,623.80 | 323,663,206.57 | 252,959,590.96 |
| 研发费用(元) | 209,881,229.54 | 146,302,173.83 | 71,964,517.95 | 260,861,479.83 | 188,135,533.21 | 123,739,625.87 | 51,904,828.32 |
| 营业税金及附加(元) | 5,126,317.49 | 3,088,599.00 | 1,174,324.79 | 15,068,503.02 | 5,644,353.55 | 3,554,230.40 | 2,921,588.49 |
| 销售费用(元) | 115,645,578.78 | 72,500,539.19 | 34,733,181.24 | 162,190,807.32 | 117,077,775.48 | 76,264,247.95 | 40,212,550.96 |
| 管理费用(元) | 301,544,840.30 | 204,636,205.23 | 90,024,520.84 | 372,357,302.08 | 249,985,608.25 | 157,735,102.42 | 77,212,870.66 |
| 财务费用(元) | -45,920,433.50 | -71,640,030.82 | -35,093,552.89 | -275,581,392.99 | -252,109,103.42 | -227,389,799.11 | -936,840.76 |
| 其中：利息费用(元) | 14,332,103.62 | 10,259,896.71 | 3,502,978.11 | 18,120,027.97 | 11,726,511.09 | 6,054,663.37 | 2,858,409.85 |
| 其中：利息收入(元) | 83,735,447.92 | 71,646,394.71 | 43,053,339.92 | 207,669,151.14 | 158,298,097.02 | 101,118,115.34 | 42,722,908.92 |
| 三、其他经营收益 | |||||||
| 加：公允价值变动收益(元) | 15,159,826.64 | 15,460,200.59 | 28,146,030.43 | -8,989,798.01 | -929,534.18 | -929,534.18 | -929,534.18 |
| 加：投资收益(元) | 70,757,363.61 | 42,503,594.04 | 15,278,250.54 | 42,014,305.37 | 30,382,391.48 | 21,401,847.77 | 10,621,780.63 |
| 其中：对联营企业和合营企业的投资收益(元) | -2,392,501.81 | -1,541,856.82 | -861,109.02 | -1,498,471.37 | -1,313,942.96 | -459,227.70 | -188,114.65 |
| 资产处置收益(元) | 904,167.89 | -55,152.15 | 6,357.94 | -178,965.39 | -162,882.94 | 94,231.78 | 142,311.32 |
| 资产减值损失(元) | -16,640,365.02 | -9,024,879.15 | -3,250,750.11 | -236,508,701.39 | -16,071,100.49 | -9,061,566.30 | 37,627,630.24 |
| 信用减值损失(元) | 419,628.48 | -6,479,045.03 | -4,688,959.56 | -27,533,764.17 | 425,768.97 | -224,963.37 | -1,121,786.65 |
| 其他收益(元) | 4,996,672.21 | 3,764,476.46 | 680,696.18 | 29,504,295.15 | 8,465,436.48 | 5,473,940.88 | 443,217.23 |
| 四、营业利润(元) | -282,546,252.62 | -159,784,405.43 | -67,454,742.43 | -383,834,660.32 | -44,437,855.43 | 60,731,225.57 | -1,445,689.02 |
| 加：营业外收入(元) | 6,887,356.75 | 3,667,750.26 | 16,204.61 | 4,211,085.85 | 4,259,386.07 | 4,211,753.76 | 664,966.17 |
| 减：营业外支出(元) | 2,028,129.64 | 1,333,238.16 | 678,704.45 | 24,603,155.94 | 6,061,549.84 | 5,726,327.51 | 36,874,313.46 |
| 五、利润总额(元) | -277,687,025.51 | -157,449,893.33 | -68,117,242.27 | -404,226,730.41 | -46,240,019.20 | 59,216,651.82 | -37,655,036.31 |
| 减：所得税费用(元) | -3,459,475.91 | 2,594,118.89 | 1,838,041.47 | 14,042,100.02 | 21,026,339.99 | 21,270,322.95 | 8,757,840.69 |
| 六、净利润(元) | -274,227,549.60 | -160,044,012.22 | -69,955,283.74 | -418,268,830.43 | -67,266,359.19 | 37,946,328.87 | -46,412,877.00 |
| (一)按经营持续性分类 | |||||||
| 持续经营净利润(元) | -274,227,549.60 | -160,044,012.22 | -69,955,283.74 | -418,268,830.43 | -67,266,359.19 | 37,946,328.87 | -46,412,877.00 |
| (二)按所有权归属分类 | |||||||
| 归属于母公司股东的净利润(元) | -262,156,256.43 | -151,607,488.56 | -67,353,495.40 | -397,583,595.27 | -72,383,980.73 | 34,807,586.49 | -50,330,075.15 |
| 少数股东损益(元) | -12,071,293.17 | -8,436,523.66 | -2,601,788.34 | -20,685,235.16 | 5,117,621.54 | 3,138,742.38 | 3,917,198.15 |
| 扣除非经常性损益后的净利润(元) | -349,927,864.12 | -207,343,354.95 | -109,011,042.72 | -430,874,729.28 | -105,460,418.06 | 8,393,872.94 | -28,592,673.77 |
| 七、每股收益 | |||||||
| 一、基本每股收益(元) | -1.32 | -0.76 | -0.33 | -1.97 | -0.36 | 0.17 | -0.30 |
| 二、稀释每股收益(元) | -1.32 | -0.76 | -0.33 | -1.97 | -0.36 | 0.17 | -0.30 |
| 八、其他综合收益(元) | -17,554,233.08 | 2,568,899.20 | -8,352,902.11 | 14,107,016.69 | 24,878,026.66 | 28,919,674.68 | -13,260,781.25 |
| 归属于母公司股东的其他综合收益(元) | -17,554,233.08 | 2,568,899.20 | -8,352,902.11 | 14,107,016.69 | 24,878,026.66 | 28,919,674.68 | -13,260,781.25 |
| 九、综合收益总额(元) | -291,781,782.68 | -157,475,113.02 | -78,308,185.85 | -404,161,813.74 | -42,388,332.53 | 66,866,003.55 | -59,673,658.25 |
| 归属于母公司所有者的综合收益总额(元) | -279,710,489.51 | -149,038,589.36 | -75,706,397.51 | -383,476,578.58 | -47,505,954.07 | 63,727,261.17 | -63,590,856.40 |
| 归属于少数股东的综合收益总额(元) | -12,071,293.17 | -8,436,523.66 | -2,601,788.34 | -20,685,235.16 | 5,117,621.54 | 3,138,742.38 | 3,917,198.15 |
| 公告日期 | 2024-10-31 | 2024-08-30 | 2024-04-30 | 2024-04-30 | 2023-10-31 | 2023-08-30 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | ||||||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 其中：利息收入(元) |
| 三、其他经营收益 |
| 加：公允价值变动收益(元) |
| 加：投资收益(元) |
| 其中：对联营企业和合营企业的投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 八、其他综合收益(元) |
| 归属于母公司股东的其他综合收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 44 of 44 entries